Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Generex Biotechnology Corp
GNBTQ
Healthcare
Biotechnology
Generex Biotechnology Corp is a Biotechnology company which is primarily engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. The company operates in the single segment being the Research and...
development of drug delivery systems and technologies for metabolic and immunological diseases. In addition, the company engages in developing proprietary vaccine formulations through its subsidiaries that work by stimulating the immune system to either attack offending agents that is cancer cells, bacteria, and viruses or to stop attacking benign elements.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (EXPM:GNBTQ)
New Post
View:
Posts & Comments
Threaded Posts
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 24, 2021 7:22pm
Covid News Feb. 24, 2021
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program Ii-Key-SARS-CoV-2 vaccine generates vaccine-specific antibodies and T cell responses in
...more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 17, 2021 7:20pm
Generex announces receipt of $2M for its COVID-19 vaccine
Published on: February 10, 2021 Author: Amy Liu Generex announces receipt of $2M or its COVID-19 vaccine development In a regulatory
...more
Lancaster Resources Receives Drill Permit Approval for Alkali Flat Lithium Brine Project
posted Apr 30, 2024 9:00am by
Lancaster Resources Inc.
-
|
"The approval of our maiden drilling application is confirmation of our commitment to responsible, minimal impact exploration and the last major hurdle before launching our maiden drilling program at Alkali Flat," says Andrew Watson, Lancaster's VP Engineering & Operations. "We are one step closer to drilling the first well at Alkali Flat and proving the ...read more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 09, 2021 11:15am
GNBT Files Trademark Application for The Complete Vaccine™
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™ Generex Biotechnology Corporation
...more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 09, 2021 11:11am
Generex Biotech Announces Call-in Details for Feb 5,2021
Update on Ii-Key-SARS-CoV-2 vaccine program China Licensing & Research Agreement advances with $100,000 payment guarantee and $1 million advance on development funding Licensing
...more
(0)
•••
nicor123
X
View Profile
View Bullboard History
Post by
nicor123
on May 26, 2020 1:08pm
reading problems
Last Friday the international clearing house that works for my Dutch broker BinckBank, gave Generex a cannabis related indication. This means that my broker no longer allows any trading in Generex. We
...more
(42)
•••
thedave2006
X
View Profile
View Bullboard History
Comment by
thedave2006
on Mar 02, 2020 9:34pm
RE:Huge News
careful on otcbb and pink sheets.
(2)
•••
Bucky12
X
View Profile
View Bullboard History
Post by
Bucky12
on Feb 28, 2020 1:43pm
Huge News
https://www.pharmaceutical-technology.com/news/generex-covid-19-vaccine/
(2)
•••
flashme1
X
View Profile
View Bullboard History
Post by
flashme1
on Jan 17, 2019 12:01pm
CTO ref# [c8887] usmj BCSC
usmj has a cto ref# [c8887] any one in B.C. canada can not trade this stock which is a parner of gnbt the holders of this stock in briyish columbia can not trade this stock and are stuck with the
...more
(0)
•••
Rx1974d
X
View Profile
View Bullboard History
Post by
Rx1974d
on Mar 23, 2017 11:37am
http://www.generex.com
Best info available at the site. D
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results